-
1.Formulations comprising antisense nucleotides to connexins 有权
Title translation: Formulierungen enthaltend Antisense Nukleotide spezifischfürConnexine公开(公告)号:EP1621212A1
公开(公告)日:2006-02-01
申请号:EP05016736.0
申请日:2000-01-27
Applicant: Becker, David, Dr. , Green, Colin R., Dr.
Inventor: Becker, David, Dr. , Green, Colin R., Dr.
CPC classification number: C07H21/04 , A61K31/711 , A61K38/00 , C12N15/111 , C12N15/1138 , C12N2310/11 , C12N2320/32
Abstract: A therapeutic and/or cosmetic formulation comprising at least one anti-sense polynucleotide to a connexin together with a pharmaceutically acceptable carrier or vehicle is useful in site specific down regulation of connexin protein expression, particularly in reduction of neuronal cells death, wound healing, reduction of inflammation, decreases of scar formation and skin rejuvenation and thickening.
Abstract translation: 包含至少一种连接蛋白的反义多核苷酸与药学上可接受的载体或载体的治疗和/或化妆品制剂可用于连接蛋白表达的位点特异性下调,特别是在减少神经元细胞死亡,伤口愈合,还原 的炎症,瘢痕形成减少和皮肤年轻化和增厚。
-
2.
公开(公告)号:EP1146908B1
公开(公告)日:2005-08-03
申请号:EP00901236.0
申请日:2000-01-27
Applicant: Becker, David, Dr. , Green, Colin R., Dr.
Inventor: BECKER, David Laurence , GREEN, Colin Richard
CPC classification number: C07H21/04 , A61K31/711 , A61K38/00 , C12N15/111 , C12N15/1138 , C12N2310/11 , C12N2320/32
-
公开(公告)号:DK1146908T3
公开(公告)日:2005-10-10
申请号:DK00901236
申请日:2000-01-27
Applicant: BECKER DAVID DR , GREEN COLIN R DR
Inventor: BECKER DAVID LAURENCE , GREEN COLIN RICHARD
-
公开(公告)号:PT1146908E
公开(公告)日:2005-10-31
申请号:PT00901236
申请日:2000-01-27
Applicant: BECKER DAVID DR , GREEN COLIN R DR
Inventor: BECKER DAVID DR , GREEN COLIN R DR
-
公开(公告)号:AT300959T
公开(公告)日:2005-08-15
申请号:AT00901236
申请日:2000-01-27
Applicant: BECKER DAVID DR , GREEN COLIN R DR
Inventor: BECKER DAVID LAURENCE , GREEN COLIN RICHARD
-
公开(公告)号:ES2377749T3
公开(公告)日:2012-03-30
申请号:ES05016736
申请日:2000-01-27
Applicant: BECKER DAVID DR , GREEN COLIN R DR , CODA THERAPEUTICS INC
Inventor: BECKER, DAVID, DR. , GREEN, COLIN R., DR.
IPC: A61K48/00 , C12N15/09 , A61K9/06 , A61K9/10 , A61K31/70 , A61K31/711 , A61K38/00 , A61K47/16 , A61K47/34 , A61K47/46 , A61P17/02 , A61P17/12 , A61P17/16 , A61P25/00 , A61P29/00 , A61P43/00 , C12N15/11 , C12N15/113
Abstract: Una formulación para uso en el tratamiento del cuerpo humano o animal mediante una terapia, cuya formulación comprende: un polinucleótido complementario de una conexina humana; junto con un soporte o un vehiculo farmaceuticamente aceptable.
-
公开(公告)号:ES2245638T3
公开(公告)日:2006-01-16
申请号:ES00901236
申请日:2000-01-27
Applicant: BECKER DAVID DR , GREEN COLIN R DR
Inventor: BECKER DAVID LAURENCE , GREEN COLIN RICHARD
IPC: C12N15/09 , A61K9/06 , A61K9/10 , A61K31/70 , A61K31/711 , A61K38/00 , A61K47/16 , A61K47/34 , A61K47/46 , A61K48/00 , A61P17/02 , A61P17/12 , A61P17/16 , A61P25/00 , A61P29/00 , A61P43/00 , C12N15/11 , C12N15/113
Abstract: Un polinucleótido antisentido para una proteína conexina para usar en el tratamiento del cuerpo humano o animal mediante terapia.
-
-
-
-
-
-